![]() |
|
|
Vol. 290, Issue 1, 380-387, July 1999
Department of Pharmacology, Universidade Federal de Santa Catarina,
SC, Brazil
We investigated the effects of the exposure of the rat vascular
system to nitric oxide (NO), using infusion of either NO donor sodium
nitroprusside (SNP) or
S-nitroso-acetyl-DL-penicillamine (SNAP) on
mean arterial pressure (MAP) responses to vasoconstrictors (phenylephrine, angiotensins I and II) and to vasodilators (bradykinin, acetylcholine, SNP, and iloprost). SNP (250 nmol/kg/ min) or SNAP (85 nmol/kg/min) infused for 30 min decreased MAP by 40 to 60 mm Hg. MAP
returned to normal levels 5 to 10 min after the end of infusion. After
infusion of SNP or SNAP the effects of phenylephrine, angiotensin I,
and angiotensin II were reduced by 40 to 80%, whereas the responses to
bradykinin or acetylcholine were enhanced by 50 to 80%. These changes
in vascular responsiveness persisted for at least 24 h after the
SNP infusion. Pretreatment with either tetraethylammonium (360 µmol/kg) or 4-aminopyridine (4-AP; 1 µmol/kg) did not alter the
effects of phenylephrine or bradykinin in control animals, but
prevented SNP-induced changes in responsiveness to phenylephrine or
bradykinin. On the other hand, administration of tetraethylammonium,
even 24 h after SNP infusion, reversed hyporesponsiveness to
phenylephrine, whereas 4-AP was ineffective. Tetraethylammonium and
4-AP did not alter the increased responses to bradykinin. Glibenclamide
was without effect in any situation. These results indicate that
NO-induced changes on vascular responsiveness to vasoconstrictors and
vasodilators are much more profound and long-lasting than described
previously and that the effects of NO appear to be, at least in part,
mediated by persistent activation of a tetraethylammonium-sensitive
population of K+ channels.
This article has been cited by other articles:
![]() |
J. L. Atkins, B. W. Day, M. T. Handrigan, Z. Zhang, M. B. Pamnani, and N. V. Gorbunov Brisk production of nitric oxide and associated formation of S-nitrosothiols in early hemorrhage J Appl Physiol, April 1, 2006; 100(4): 1267 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Alencar, I. Lobysheva, K. Chalupsky, M. Geffard, F. Nepveu, J.-C. Stoclet, and B. Muller S-Nitrosating Nitric Oxide Donors Induce Long-Lasting Inhibition of Contraction in Isolated Arteries J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 152 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Alencar, I. Lobysheva, M. Geffard, M. Sarr, C. Schott, V. B. Schini-Kerth, F. Nepveu, J.-C. Stoclet, and B. Muller Role of S-Nitrosation of Cysteine Residues in Long-Lasting Inhibitory Effect of Nitric Oxide on Arterial Tone Mol. Pharmacol., May 1, 2003; 63(5): 1148 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Benjamim, J. S. Silva, Z. B. Fortes, M. A. Oliveira, S. H. Ferreira, and F. Q. Cunha Inhibition of Leukocyte Rolling by Nitric Oxide during Sepsis Leads to Reduced Migration of Active Microbicidal Neutrophils Infect. Immun., July 1, 2002; 70(7): 3602 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Da Silva-Santos, M. C. Santos-Silva, F. d. Q. Cunha, and J. Assreuy The Role of ATP-Sensitive Potassium Channels in Neutrophil Migration and Plasma Exudation J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 946 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Muscara, W. McKnight, F. Lovren, C. R. Triggle, G. Cirino, and J. L. Wallace Antihypertensive properties of a nitric oxide-releasing naproxen derivative in two-kidney, one-clip rats Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H528 - H535. [Abstract] [Full Text] [PDF] |
||||